Rounded Weekly – Daily Edition: 30 May 2024
The daily edition of Rounded Weekly for 30 May 2024. A round-up of the top 10 closed startup rounds for the day, with the day's top news at the bottom.
How’s everyone doing?
Today, we’re a little earlier with the newsletter. I noticed that sending it out later affected the open rate, so clearly works better for some, but not for others. Thus, I’m experimenting with today’s by going a little earlier, catching mid-afternoon EST. I’ll get the ideal send time nailed down – experimenting is key! Side note: I’m away Fri-Sun and officially OOO, so I’ll probably pause Rounded Weekly for these days – but we’ll be back to our regularly scheduled programming next week.
And, as always, f you find this edition helpful, please share it with someone you know! Your support is super helpful to help the newsletter grow. I’ve gained over 10% of Rounded Weekly subscribers since soft-launching last week, and we’re getting new sign-ups every day. It’s very encouraging to see, and I appreciate everyone subscribing.
If you’re new around here, my intention of Rounded Weekly is to bring you the hottest rounds closed weekly (and now with a daily edition). Think of it as a personal Crunchbase, but for the rounds you actually care about. I want to make sure you’re as in the loop as possible, whether it’s for watercooler talk, identifying market trends, or just staying in the know.
Today’s list:
1. Insmed
Funding Type: Post-IPO Equity
Amount Raised: $65 Million USD
Insmed is a global biopharmaceutical company focused on developing therapies for patients with serious and rare diseases. Their innovative treatments address unmet medical needs and improve the quality of life for patients worldwide. The Post-IPO Equity funding will support the advancement of their pipeline and expansion of their global reach.
Something I like about them: Insmed's dedication to addressing unmet medical needs through innovative therapies is highly impactful. Their work has the potential to significantly improve patient outcomes and advance the field of biopharmaceuticals.
2. Astek Group
Funding Type: Debt Financing
Amount Raised: $48.56 Million USD
Astek Group is an international engineering and technology consulting firm. They provide innovative solutions across various industries, including automotive, aerospace, and information technology. The Debt Financing will enable Astek Group to expand its service offerings and invest in new technological advancements.
Something I like about them: Astek Group's commitment to providing cutting-edge engineering and technology solutions is impressive. Their innovative approach helps clients across various industries achieve their goals and drive technological progress.
3. Verdant Commercial Capital
Funding Type: Debt Financing
Amount Raised: $30.77 Million USD
Verdant Commercial Capital is a financing company that provides flexible and customized financing solutions for businesses. They specialize in equipment financing, vendor programs, and commercial lending. The Debt Financing round will support their efforts to provide innovative financing options to a broader range of clients.
Something I like about them: Verdant Commercial Capital's focus on offering customized financing solutions is highly beneficial for businesses. Their flexible approach helps clients secure the funding they need to grow and succeed.
4. SEDEMAC
Funding Type: Venture - Series Unknown
Amount Raised: $100 Million USD
SEDEMAC is a technology company that develops innovative control systems for engines and powertrains. Their products enhance the efficiency and performance of various mechanical systems. The funding will support the development of new technologies and the expansion of their market presence.
Something I like about them: SEDEMAC's innovative control systems significantly improve the efficiency and performance of engines and powertrains. Their technologies contribute to advancements in the automotive and mechanical industries.
5. Investment AB Latour
Funding Type: Post-IPO Debt
Amount Raised: $94.17 Million USD
Investment AB Latour is a Swedish investment company with a diverse portfolio that includes both wholly owned industrial operations and a significant shareholding in listed companies. The Post-IPO Debt funding will be used to support further investments and acquisitions to grow their portfolio.
Something I like about them: Investment AB Latour's strategic investments and acquisitions drive growth and value creation. Their diversified portfolio ensures stability and long-term success.
6. Cisco Equipment
Funding Type: Debt Financing
Amount Raised: $75 Million USD
Cisco Equipment is a leading provider of equipment solutions for construction, agriculture, and other industries. They offer a wide range of equipment for sale, lease, and rent, backed by comprehensive service and support. The Debt Financing will enable Cisco Equipment to expand its inventory and enhance its service offerings.
Something I like about them: Cisco Equipment's extensive range of equipment solutions and strong service support help clients maximize productivity and efficiency. Their commitment to customer satisfaction is evident in their comprehensive offerings.
7. CinRx Pharma
Funding Type: Venture - Series Unknown
Amount Raised: $73 Million USD
CinRx Pharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for unmet medical needs. Their pipeline includes therapies for a range of conditions, aiming to bring new options to patients who need them most. The funding will support the advancement of their clinical programs and the expansion of their research efforts.
Something I like about them: CinRx Pharma's commitment to developing innovative treatments for unmet medical needs is highly impactful. Their work has the potential to bring new hope to patients and advance the field of biopharmaceuticals.
8. Celcuity
Funding Type: Post-IPO Equity
Amount Raised: $60 Million USD
Celcuity is a biotechnology company that uses a proprietary technology platform to discover new cancer subtypes and identify the most effective therapies for patients. Their innovative approach helps to tailor treatments to individual patients, improving outcomes and reducing side effects. The Post-IPO Equity funding will support the development of their platform and the expansion of their clinical programs.
Something I like about them: Celcuity's personalized approach to cancer treatment is transformative. Their technology helps to ensure that patients receive the most effective therapies, improving outcomes and quality of life.
9. FintechOS
Funding Type: Series B
Amount Raised: $60 Million USD
FintechOS is a fintech company that provides a low-code platform for digital transformation in financial services. Their technology enables banks and insurers to quickly build and launch innovative digital products and services. The Series B funding will support the development of new features and the expansion of their platform.
Something I like about them: FintechOS's low-code platform empowers financial institutions to innovate rapidly. Their technology helps clients stay competitive in a fast-changing industry, driving digital transformation and customer satisfaction.
10. Natural Cycles
Funding Type: Series C
Amount Raised: $55 Million USD
Natural Cycles is a digital health company that offers a contraceptive app based on fertility awareness. The app uses an algorithm to analyze menstrual cycle data and predict fertile days, helping women to prevent or plan pregnancies naturally. The Series C funding will support the further development of their app and the expansion of their user base.
Something I like about them: Natural Cycles' innovative approach to fertility awareness and contraception is empowering for women. Their app provides a natural and effective option for family planning, supported by scientific research and data.
Today’s Top News
Paul Graham claims Sam Altman wasn’t fired from Y Combinator
Spotify offers Car Thing refunds as it faces lawsuit over bricking the streaming device
The world’s first tooth-regrowing drug has been approved for human trials
Amazon has permission to fly its drones over longer distances
That's my selection of the top 10 rounds from today. Congratulations to all the teams behind these startups for their achievements! Be sure to check out their websites if you want to learn more. And to keep updated on the rounds, make sure you’re subscribed to Rounded Weekly.
Be sure to follow me on Twitter/X @connorjewiss, so you don’t miss any updates, news, or insights. I hope you’ll stick with the newsletter now that I’ve worked out exactly what I want it to be.
See you tomorrow 👋